Amalgamated Bank’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16K | Hold |
5,042
| – | – | ﹤0.01% | 2192 |
|
2025
Q1 | $18K | Buy |
5,042
+594
| +13% | +$2.12K | ﹤0.01% | 2082 |
|
2024
Q4 | $15K | Hold |
4,448
| – | – | ﹤0.01% | 2225 |
|
2024
Q3 | $17K | Hold |
4,448
| – | – | ﹤0.01% | 2183 |
|
2024
Q2 | $14K | Buy |
4,448
+666
| +18% | +$2.1K | ﹤0.01% | 2259 |
|
2024
Q1 | $10K | Sell |
3,782
-10,899
| -74% | -$28.8K | ﹤0.01% | 2419 |
|
2023
Q4 | $37K | Sell |
14,681
-1,126
| -7% | -$2.84K | ﹤0.01% | 2369 |
|
2023
Q3 | $32K | Hold |
15,807
| – | – | ﹤0.01% | 2438 |
|
2023
Q2 | $36K | Buy |
15,807
+2,060
| +15% | +$4.69K | ﹤0.01% | 2449 |
|
2023
Q1 | $42K | Sell |
13,747
-1,938
| -12% | -$5.92K | ﹤0.01% | 2364 |
|
2022
Q4 | $37K | Hold |
15,685
| – | – | ﹤0.01% | 2548 |
|
2022
Q3 | $30K | Buy |
15,685
+148
| +1% | +$283 | ﹤0.01% | 2666 |
|
2022
Q2 | $42K | Buy |
15,537
+5,441
| +54% | +$14.7K | ﹤0.01% | 2564 |
|
2022
Q1 | $30K | Buy |
+10,096
| New | +$30K | ﹤0.01% | 2673 |
|